Celcuity (CELC) Cash & Equivalents (2016 - 2025)
Celcuity (CELC) posted Cash & Equivalents of $441.5 million for Q4 2025, up 494.6% on a QoQ basis from $74.3 million in Q3 2025, and up 1862.22% year-over-year from $22.5 million in Q4 2024.
Celcuity (CELC) Cash & Equivalents (2016 - 2025) Analysis & Trends
Celcuity's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $441.5 million for Q4 2025.
- Quarterly Cash & Equivalents rose 1862.22% year-over-year to $441.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $441.5 million (up 1862.22% YoY) and the FY2025 annual result came in at $441.5 million, up 1862.22% from the prior year.
- Cash & Equivalents was $441.5 million for Q4 2025 at Celcuity, up from $74.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $441.5 million in Q4 2025 and bottomed at $12.6 million in Q3 2024.
- A 5-year average of $63.8 million and a median of $34.3 million in 2021 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 70.85% — and 2025, when it jumped 1862.22%.
- Celcuity's Cash & Equivalents stood at $84.3 million in 2021, then tumbled by 70.85% to $24.6 million in 2022, then rose by 24.79% to $30.7 million in 2023, then retreated by 26.62% to $22.5 million in 2024, then soared by 1862.22% to $441.5 million in 2025.
- Business Quant data shows CELC's Cash & Equivalents at $441.5 million in Q4 2025, $74.3 million in Q3 2025, and $46.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 441.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 441.50 Mn |
| Sep 30, 2025 | 74.25 Mn |
| Jun 30, 2025 | 46.35 Mn |
| Mar 31, 2025 | 16.48 Mn |
| Dec 31, 2024 | 22.50 Mn |
| Sep 30, 2024 | 12.60 Mn |
| Jun 30, 2024 | 30.46 Mn |
| Mar 31, 2024 | 31.21 Mn |
| Dec 31, 2023 | 30.66 Mn |
| Sep 30, 2023 | 25.76 Mn |
| Jun 30, 2023 | 32.24 Mn |
| Mar 31, 2023 | 33.64 Mn |
| Dec 31, 2022 | 24.57 Mn |
| Sep 30, 2022 | 57.48 Mn |
| Jun 30, 2022 | 66.91 Mn |
| Mar 31, 2022 | 78.30 Mn |
| Dec 31, 2021 | 84.29 Mn |
| Sep 30, 2021 | 90.37 Mn |
| Jun 30, 2021 | 41.64 Mn |
| Mar 31, 2021 | 34.94 Mn |